Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 3Multiple Myeloma 2Colorectal Neoplasms 2Uterine Cervical Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteonecrosis 1Lymphoma 1Lung Neoplasms 1Hypertension 1Hematologic Neoplasms 1Depression 1Bone Neoplasms 1Anxiety Disorders 1Anatomic Stage I Breast Cancer AJCC v8 1Acquired Immunodeficiency Syndrome 1

Interventions

Bevacizumab 112Fluorouracil 98Oxaliplatin 96Leucovorin 96Irinotecan 86Capecitabine 73Cetuximab 64Panitumumab 42pembrolizumab 38regorafenib 28Nivolumab 23IFL protocol 22Folfox protocol 21trifluridine tipiracil drug combination 14Radiotherapy 13durvalumab 11Gemcitabine 10Celecoxib 9tremelimumab 7binimetinib 7aflibercept 7Drug Therapy 7Disulfides 7Cyclophosphamide 7Trifluridine 6Trastuzumab 6Sunitinib 6Immunoglobulin G 6Colonoscopy 6130-nm albumin-bound paclitaxel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Colorectal Neoplasms × Interviews as Topic × Clear all
NCT04890054 2025-08-19

SMARTER CRC

OHSU Knight Cancer Institute

Phase NA Completed
5,696 enrolled 19 charts
Gastrointestinal

Colorectal Neoplasms

NCT03520283 2021-04-19

Systems Support Mapping in Guiding Self-Management in Stage I-III Colorectal Cancer Survivors

Wake Forest University Health Sciences

Phase NA Completed
24 enrolled 35 charts
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡